Skip to main navigation Skip to search Skip to main content

First-line all-oral NORCAP (vinorelbine/capecitabine) might be alternative to taxane-based chemotherapy for HER2-negative metastatic breast cancer

  • Kadri Altundag

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Pages (from-to)385
Number of pages1
JournalBreast Cancer Research and Treatment
Volume161
Issue number2
DOIs
Publication statusPublished - 1 Jan 2017
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this